Recombinant Tumor-Infiltrating Lymphocyte TCR Therapy (GigaMune)

N/A

Report date: 2025/01/26 15:14:19

Base Information

Drug NameRecombinant Tumor-Infiltrating Lymphocyte TCR Therapy (GigaMune)

Drug Alias NamePolyclonal TCR T-cell Therapy (GigaMune)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGigaMune Inc

China Registration ClassN/A

Develop Information

Active CompaniesGigaMune Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A